Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Clin Imaging. 2017 Feb 10;43:97–105. doi: 10.1016/j.clinimag.2017.01.015

Table 3.

Costs, Effectiveness and Incremental Cost Effectiveness Ratio for Individuals With a 80% Prevalence of Obstructive CAD

Strategy Cost Effect Δ Cost Δ Effect ICER
ETT-MPS-ICA $31,498 13.9581
ETT-SE-ICA $31,747 13.9646 $249 0.0065 $38,234
MPS-CCTA-ICA $32,554 13.9678 $807 0.0032 Ext Dominated
ETT-CCTA-ICA $32,554 13.9749 $808 0.0103 $78,404
MPS-ICA $32,624 13.9684 $69 −0.0065 Dominated
SE-CCTA-ICA $32,956 13.9784 $401 0.0035 Ext Dominated
SE-ICA $33,026 13.979 $70 0.0006 Ext Dominated
ETT-ICA $33,196 13.9804 $170 0.0014 Ext Dominated
CCTA-MPS-ICA $34,144 13.993 $948 0.0126 Ext Dominated
CCTA-SE-ICA $34,171 13.9938 $1,616 0.0189 $85,523
CCTA-ICA $34,330 13.9955 $160 0.0017 $93,841
ICA $35,366 14.0044 $1,035 0.0089 $116,337